Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 69
Filtrar
1.
Eur Rev Med Pharmacol Sci ; 26(8): 2794-2801, 2022 04.
Artículo en Inglés | MEDLINE | ID: mdl-35503624

RESUMEN

OBJECTIVE: The nitric oxide (NO) metabolite nitrite has been shown to attenuate hyperglycemia via its increase in insulin sensitivity and glucose uptake. However, the oral use of nitrite is limited due to its potential formation of the carcinogenic N-nitrosamines via reaction of acidic nitrite and the secondary amines. We investigated the anti-diabetic effect of sodium nitrite (SN) combined with glutathione (GSH) in streptozotocin (STZ)-induced diabetic mice for potential use of GSH as a protective agent in future nitrite therapy. MATERIALS AND METHODS: STZ-induced diabetic mice were orally treated for 5 weeks with vehicle, SN, GSH or SN + GSH. Oral glucose tolerance test and the measurement of fasting blood glucose (FBG) and glycosylated hemoglobin (HbA1c) levels were carried out to evaluate anti-diabetic effects of SN and SN + GSH. Plasma levels of total NO metabolites (NOx) were measured to confirm nitrite absorption. RESULTS: SN and SN + GSH significantly improved the glucose tolerance (p < 0.05), but GSH alone did not. The efficacy of combination treatment with SN and GSH in improving the glucose tolerance was higher than that of SN alone. Oral treatment with SN or SN + GSH significant reduced FBG and HbA1c levels (p < 0.05). Interestingly, daily oral administration of SN + GSH was more effective in reducing FBG and HbA1c levels than that of SN alone. Administration of SN or SN + GSH significantly increased plasma NOx levels (p < 0.05), and combination treatment with SN + GSH was more effective in increasing plasma NOx levels than that with SN alone. CONCLUSIONS: Combination treatment with SN and GSH is more effective in controlling hyperglycemia and increasing the plasma NOx levels in an experimental mouse model of diabetes. Since oral administration of GSH has been shown to be non-toxic in humans, the combination of SN and GSH may be important in potential future nitrite therapy.


Asunto(s)
Diabetes Mellitus Experimental , Glutatión , Hiperglucemia , Nitrito de Sodio , Animales , Antioxidantes/administración & dosificación , Antioxidantes/metabolismo , Glucemia/metabolismo , Diabetes Mellitus Experimental/metabolismo , Glucosa/metabolismo , Glutatión/administración & dosificación , Hemoglobina Glucada/metabolismo , Hiperglucemia/tratamiento farmacológico , Ratones , Óxido Nítrico/metabolismo , Nitrito de Sodio/administración & dosificación , Estreptozocina
2.
J Periodontal Res ; 45(2): 177-83, 2010 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-20470258

RESUMEN

BACKGROUND AND OBJECTIVE: Although heme oxygenase-1 (HO-1) plays a key role in inflammation, its anti-inflammatory effects and mechanism of action in periodontitis are still unknown. This study aimed to identify the effects of HO-1 on the proinflammatory mediators activated by nicotine and lipopolysaccharide (LPS) stimulation in human periodontal ligament (PDL) cells. MATERIAL AND METHODS: The production of nitric oxide (NO) and prostaglandin E(2) (PGE(2)) was evaluated using Griess reagent and an enzyme immunoassay, respectively. The expression of inducible nitric oxide synthase (iNOS), cyclooxygenase-2 (COX-2) and HO-1 proteins was evaluated by Western blot analysis. RESULTS: Lipopolysaccharide and nicotine synergistically induced the production of NO and PGE(2) and increased the protein expression of iNOS, COX-2 and HO-1. Treatment with an HO-1 inhibitor and HO-1 small interfering RNAs blocked the LPS- and nicotine-stimulated NO and PGE(2) release as well as the expression of iNOS and COX-2. CONCLUSION: Our data suggest that the nicotine- and LPS-induced inflammatory effects on PDL cells may act through a novel mechanism involving the action of HO-1. Thus, HO-1 may provide a potential therapeutic target for the treatment of periodontal disease associated with smoking and dental plaque.


Asunto(s)
Ciclooxigenasa 2/efectos de los fármacos , Hemo-Oxigenasa 1/farmacología , Lipopolisacáridos/farmacología , Nicotina/farmacología , Óxido Nítrico Sintasa de Tipo II/efectos de los fármacos , Ligamento Periodontal/efectos de los fármacos , Androstadienos/farmacología , Antracenos/farmacología , Línea Celular , Inhibidores de la Ciclooxigenasa 2/farmacología , Dinoprostona/análisis , Dinoprostona/antagonistas & inhibidores , Inhibidores Enzimáticos/farmacología , Hemo-Oxigenasa 1/antagonistas & inhibidores , Hemo-Oxigenasa 1/genética , Humanos , Mediadores de Inflamación/análisis , Proteínas Quinasas JNK Activadas por Mitógenos/antagonistas & inhibidores , Metaloporfirinas/farmacología , FN-kappa B/efectos de los fármacos , Óxido Nítrico/análisis , Óxido Nítrico/antagonistas & inhibidores , Óxido Nítrico Sintasa de Tipo II/antagonistas & inhibidores , Ligamento Periodontal/citología , Ligamento Periodontal/enzimología , Inhibidores de las Quinasa Fosfoinosítidos-3 , Protoporfirinas/farmacología , ARN Interferente Pequeño/genética , ARN Interferente Pequeño/farmacología , Transfección , Wortmanina
3.
Eur Rev Med Pharmacol Sci ; 21(4): 890-899, 2017 02.
Artículo en Inglés | MEDLINE | ID: mdl-28272690

RESUMEN

OBJECTIVE: Nephrotoxicity is one of the major side effects that limit the use of cisplatin in cancer therapy. Cisplatin-induced apoptosis in renal cells is associated with reactive oxygen species (ROS)-mediated p53 activation. Licorice (Glycyrrhiza uralensis Fischer) is one of the most widely used medicinal herbs in Korea, China and Japan. The aim of the study was to evaluate the protective effects of licorice extract (LE) and its active compound glycyrrhizic acid (GA) against cisplatin-induced nephrotoxicity in human renal proximal tubular epithelial (HK-2) cells. MATERIALS AND METHODS: HK-2 cells were pretreated with LE or GA for 1 h and then treated with 40 µM of cisplatin for indicated times under the serum-free condition. Cell viability was evaluated by MTT assay. Apoptosis was evaluated by flow cytometric analysis and caspase-3 activity. The intracellular ROS levels were determined by DCFH-DA assay. The expression and phosphorylation levels of protein were evaluated by Western blot and densitometry analysis. RESULTS: When treating HK-2 cells with LE or GA, both of them alleviated cisplatin-induced cytotoxicity and apoptosis. LE and GA inhibited caspase-3 activity and polymerase (PARP) cleavage in cisplatin-treated cells. LE and GA also inhibited p53 expression and its phosphorylation as well as ROS production in cells exposed to cisplatin. Meanwhile, LE and GA enhanced cisplatin-induced p21 expression, which then led to S-phase arrest in cell cycle and limited cell growth. Presumably, increased p21 expression may contribute to cellular prevention from cisplatin-induced apoptosis, because p21 is the key molecule to cytoprotection during cisplatin-induced nephrotoxicity. CONCLUSIONS: These results suggest that LE and GA ameliorate cisplatin-induced apoptosis through reduction of ROS-mediating p53 activation and promotion of p21 expression in HK-2 cells.


Asunto(s)
Cisplatino/efectos adversos , Células Epiteliales/efectos de los fármacos , Ácido Glicirrínico/farmacología , Extractos Vegetales/farmacología , Especies Reactivas de Oxígeno/metabolismo , Antineoplásicos/efectos adversos , Apoptosis/efectos de los fármacos , Línea Celular , Inhibidor p21 de las Quinasas Dependientes de la Ciclina/metabolismo , Células Epiteliales/metabolismo , Glycyrrhiza/química , Humanos , Túbulos Renales Proximales/citología , Proteína p53 Supresora de Tumor/metabolismo
4.
J Dent Res ; 85(6): 515-9, 2006 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-16723647

RESUMEN

UNLABELLED: Cyclosporine A (CsA) is a widely used immunosuppressant but with significant side-effects, such as gingival overgrowth. This study investigates how CsA induces gingival proliferation and shows the effects of the CsA-associated signaling messengers, IL-6 and TGF-beta1, on gingival proliferation. CsA increased both IL-6 and TGF-beta1 levels. In addition to CsA, an IL-6 or TGF-beta1 treatment also induced gingival fibroblast proliferation. Inhibiting the cytokine resulted in the suppression of CsA-induced proliferation. MAPKs and PI3K are known to be involved in cell proliferation. Therefore, the effect of CsA on the kinase activities was examined. The results showed that both p38 MAPK and PI3K are essential for gingival fibroblast proliferation. TGF-beta1 and IL-6 and their associated signaling transduction may be novel bona fide molecular targets for the prevention of gingival overgrowth in CsA-treated patients. ( ABBREVIATIONS: MAPK, mitogen-activated protein kinase; P13K, phosphatidylinositol 3-kinase.)


Asunto(s)
Ciclosporina/farmacología , Encía/efectos de los fármacos , Sobrecrecimiento Gingival/inducido químicamente , Inmunosupresores/farmacología , Northern Blotting , Recuento de Células , Proliferación Celular/efectos de los fármacos , Células Cultivadas , Quinasas MAP Reguladas por Señal Extracelular/efectos de los fármacos , Fibroblastos/efectos de los fármacos , Encía/citología , Humanos , Immunoblotting , Inmunoprecipitación , Interleucina-6/farmacología , MAP Quinasa Quinasa 4/efectos de los fármacos , Fosfatidilinositol 3-Quinasas/efectos de los fármacos , Transducción de Señal/efectos de los fármacos , Factores de Tiempo , Factor de Crecimiento Transformador beta/efectos de los fármacos , Factor de Crecimiento Transformador beta/farmacología , Factor de Crecimiento Transformador beta1 , Proteínas Quinasas p38 Activadas por Mitógenos/efectos de los fármacos
5.
Clin Chim Acta ; 365(1-2): 270-8, 2006 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-16242122

RESUMEN

BACKGROUND: Carbon monoxide (CO) and nitric oxide (NO) each have unique roles for various inflammatory states, including inflammatory bone resorption. Although it is known that NO can induce the expression of the cytoprotective enzyme HO-1, there is no information as to whether the protective effect of CO requires NO production or whether CO must induce the expression of HO-1 to exert its functional effects. METHODS: Murine osteoblast cells, MC3T3E1 osteoblasts, were cultured for CO and NO-associated HO-1 experiments and were transfected with pcDNA 3, pcDNA 3-HO-1, control siRNA or HO-1 siRNA using Nucleofector. For cell death measurement, MTT and annexin V assays were used. We performed Western blotting to check the expressions of HO-1 and iNOs and measured the HO-1 enzyme activity. We also measured the amounts of nitrite and nitrate using Griess reagents. RESULTS: The increased expression of HO-1 is required for the protective effect of NO and a single treatment of CO can increase the expression of HO-1, and this is also important for the protective effect of CO in MC3T3E1 osteoblasts. CO as well as NO attenuates the TNF-alpha-induced apoptosis in osteoblasts. The anti-apoptotic effect of CO or NO is not mediated by cGMP, and CO has no effect on the release of NO. The inhibition of HO-1 with using the HO-1 inhibitor ZnPP or HO-1 siRNA resulted in a striking increase of apoptosis in the CO/TNF-alpha-treated cells. Furthermore, HO-1 overexpression showed resistance against the TNF-alpha-induced cytotoxicity in the MC3T3E1 osteoblasts. CONCLUSIONS: There is a need for HO-1 expression to mediate the protection provided by exogenous CO or NO in osteoblasts.


Asunto(s)
Apoptosis/fisiología , Monóxido de Carbono/fisiología , Hemo Oxigenasa (Desciclizante)/metabolismo , Óxido Nítrico/fisiología , Osteoblastos/citología , Factor de Necrosis Tumoral alfa/fisiología , Células 3T3 , Animales , Western Blotting , Ratones , Osteoblastos/enzimología
6.
Eur Rev Med Pharmacol Sci ; 19(16): 3125-32, 2015 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-26367737

RESUMEN

OBJECTIVE: Endothelial dysfunction associated with many cardiovascular diseases is largely due to reduced nitric oxide (NO) derived from endothelial NO synthase (eNOS). Piceatannol (trans-3,4,3',5'-tetrahydroxystilbene; Pic) is reported to have cardiovascular therapeutic effects. However, the cellular and molecular mechanisms underlying the cardioprotective effects of Pic are still unclear. Here, we investigated whether Pic could influence endothelial NO release in human umbilical vein endothelial cells (HUVECs). MATERIALS AND METHODS: In HUVECs exposed to Pic, NO production and phosphorylation of eNOS and protein kinase B (Akt) were determined by using a commercially available NO assay kit and Western blot analysis, respectively. RESULTS: Pic stimulated dose- and time-dependent NO production via eNOS phosphorylation. Pic also stimulated dose-dependent phosphorylation of Akt. Interestingly, NO production and eNOS phosphorylation in response to Pic were significantly abolished by the phosphoinositide 3-kinase (PI3K)/Akt inhibitor LY294002. CONCLUSIONS: Pic is capable of inducing eNOS phosphorylation and the subsequent NO release, presumably, by activating PI3K/Akt pathway. The potential efficacy of Pic, a natural hydroxylated analog and a metabolite of resveratrol, may aid in the prevention of cardiovascular diseases characterized by endothelial dysfunction.


Asunto(s)
Células Endoteliales/efectos de los fármacos , Óxido Nítrico Sintasa de Tipo III/metabolismo , Óxido Nítrico/metabolismo , Estilbenos/farmacología , Células Cultivadas , Células Endoteliales/enzimología , Células Endoteliales/metabolismo , Humanos , Fosfatidilinositol 3-Quinasas/metabolismo , Fosforilación/efectos de los fármacos
7.
Eur Rev Med Pharmacol Sci ; 19(12): 2303-10, 2015 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-26166660

RESUMEN

OBJECTIVE: Indoxyl sulfate (IS) has been reported to induce endoplasmic reticulum (ER) stress in tubular cells and to inhibit the cell proliferation via ER stress and ERK/IL-6/p21 pathways. This study has investigated the effect of apigenin on IS-induced ER stress in immortalized human renal proximal tubular HK-2 cells. MATERIALS AND METHODS: Human Kidney 2 (HK-2) cells were treated with IS (5 mM) in the absence or presence of apigenin (10 µM) or salubrinal (20 µM) for indicated times under the serum-free condition. Cell viability was evaluated by MTT assay. The levels of protein expression and phosphorylation were evaluated by Western blot analysis. RESULTS: In HK-2 cells, apigenin completely inhibited IS-induced ER stress, as indicated by decreased expression of CHOP, ATF4 and GRP78, although the phosphorylated level of eIF2α did not decrease. IS-induced expression levels of IL-6 and p21 proteins were also inhibited by apigenin, with no significant changes in ERK activation. The suppression of cell proliferation by IS was abolished by salubrinal, an ER stress inhibitor, but not by apigenin. Apigenin inhibited the phosphorylation of Akt and GSK-3ß in IS-treated HK-2 cells. The phosphorylation of GSK-3ß, which was inhibited by apigenin, resulted in hypo-phosphorylation of retinoblastoma (Rb) protein, which was associated with the decrease in cyclin D1 expression. CONCLUSIONS: These results suggest that apigenin may inhibit IS-induced ER stress and expression of IL-6 and p21 proteins in HK-2 cells. It is most likely that apigenin, together with its inhibitory effect on ER stress, may also suppress the cell growth by inducing the loss of Rb phosphorylation, which was associated with the decrease in cyclin D1 expression by GSK-3ß activation through the inhibition of PI3K/Akt pathway.


Asunto(s)
Apigenina/farmacología , Inhibidor p21 de las Quinasas Dependientes de la Ciclina/biosíntesis , Estrés del Retículo Endoplásmico/fisiología , Indicán/toxicidad , Interleucina-6/biosíntesis , Túbulos Renales Proximales/metabolismo , Factor de Transcripción CHOP/biosíntesis , Ciclo Celular/efectos de los fármacos , Ciclo Celular/fisiología , Línea Celular Transformada , Proliferación Celular/efectos de los fármacos , Proliferación Celular/fisiología , Inhibidor p21 de las Quinasas Dependientes de la Ciclina/antagonistas & inhibidores , Chaperón BiP del Retículo Endoplásmico , Estrés del Retículo Endoplásmico/efectos de los fármacos , Humanos , Indicán/antagonistas & inhibidores , Interleucina-6/antagonistas & inhibidores , Túbulos Renales Proximales/efectos de los fármacos , Factor de Transcripción CHOP/antagonistas & inhibidores
8.
Free Radic Biol Med ; 28(3): 390-6, 2000 Feb 01.
Artículo en Inglés | MEDLINE | ID: mdl-10699750

RESUMEN

The effects of ionizing irradiation on the nitric oxide (NO) production in murine embryonic liver cell line, BNL CL.2 cells, were investigated. Various doses (5-40 Gy) of radiation made BNL CL.2 cells responsive to interferon-gamma alone for the production of NO in a dose-dependent manner. Small amounts of lipopolysaccharide (LPS) or tumor necrosis factor-alpha (TNF-alpha) synergized with IFN-gamma in the production of NO from irradiated BNL CL.2 cells, even though LPS or TNF-alpha alone did not induce NO production from the same cells. Immunoblots showed parallel induction of inducible nitric oxide synthase (iNOS). NO production in irradiated BNL CL.2 cells by IFN-gamma or IFN-gamma plus LPS was decreased by the addition of catalase, suggesting that H(2)O(2) produced by ionizing irradiation primed the cells to trigger NO production in response to IFN-gamma or IFN-gamma plus LPS. Furthermore, the treatment of nongamma-irradiated BNL CL.2 cells with H(2)O(2) made the cells responsive to IFN-gamma or IFN-gamma plus LPS for the production of NO. This study shows that ionizing irradiation has the ability to induce iNOS gene expression in responsive to IFN-gamma via the formation of H(2)O(2) in BNL CL.2 murine embryonic liver cells.


Asunto(s)
Rayos gamma , Interferón gamma/farmacología , Lipopolisacáridos/farmacología , Óxido Nítrico Sintasa/biosíntesis , Animales , Línea Celular , Embrión de Mamíferos , Inducción Enzimática/efectos de los fármacos , Inducción Enzimática/efectos de la radiación , Peróxido de Hidrógeno/metabolismo , Cinética , Hígado , Ratones , Óxido Nítrico/metabolismo , Proteínas Recombinantes/farmacología , Salmonella enteritidis , Factor de Necrosis Tumoral alfa/farmacología
9.
Cancer Lett ; 205(1): 23-9, 2004 Mar 08.
Artículo en Inglés | MEDLINE | ID: mdl-15036657

RESUMEN

Ginsenosides from Panax ginseng are metabolized by human intestinal bacteria after oral administration of ginseng extract. 20(S)-Protopanaxatriol (PPT) is one of the major metabolites of ginsenosides. Inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2) are important enzymes that mediate inflammatory processes. Improper up-regulation of iNOS and/or COX-2 has been associated with the pathogenesis of inflammatory diseases and certain types of human cancers. Here, we investigated whether PPT could modulate iNOS and COX-2 expressions in RAW 264.7 macrophages stimulated with the endotoxin lipopolysaccharide (LPS). We found that PPT blocked the increase in LPS-induced iNOS and COX-2 expressions through inactivation of nuclear factor-kappaB by preventing I-kappaBalpha phosphorylation and degradation. Thus, it may be possible to develop PPT as a useful agent for chemoprevention of cancer or inflammatory diseases.


Asunto(s)
Isoenzimas/efectos de los fármacos , Macrófagos/efectos de los fármacos , FN-kappa B/efectos de los fármacos , Óxido Nítrico Sintasa/efectos de los fármacos , Prostaglandina-Endoperóxido Sintasas/efectos de los fármacos , Sapogeninas/farmacología , Triterpenos/farmacología , Animales , Western Blotting , Células Cultivadas , Ciclooxigenasa 2 , Ensayo de Cambio de Movilidad Electroforética , Ginsenósidos/metabolismo , Isoenzimas/biosíntesis , Lipopolisacáridos/farmacología , Activación de Macrófagos , Macrófagos/metabolismo , Ratones , FN-kappa B/metabolismo , Óxido Nítrico Sintasa/biosíntesis , Óxido Nítrico Sintasa de Tipo II , Prostaglandina-Endoperóxido Sintasas/biosíntesis
10.
Cancer Lett ; 174(1): 17-24, 2001 Dec 10.
Artículo en Inglés | MEDLINE | ID: mdl-11675148

RESUMEN

The root of Paeonia suffruticosa ANDREWS is an important Chinese crude drug used in many traditional prescriptions. 1,2,3,4,6-penta-O-galloyl-beta-D-glucose (PGG), a major component of this crude drug, was found to exhibit in vitro growth-inhibiting effect on human hepatocellular carcinoma cell line, SK-HEP-1 cells. The growth-inhibitory effect was related to the ability of PGG not only to cause a G(0)/G(1) phase arrest but also to suppress the activation of nuclear factor-kappa B. Neither apoptosis nor necrosis was observed in the cells treated with PGG. These findings suggest that PGG could be a candidate for developing a low-toxic anticancer agent.


Asunto(s)
Antineoplásicos/farmacología , Carcinoma Hepatocelular/patología , Taninos Hidrolizables , Taninos/farmacología , Apoptosis/efectos de los fármacos , División Celular/efectos de los fármacos , ADN/metabolismo , Ensayo de Cambio de Movilidad Electroforética , Fase G1/efectos de los fármacos , Humanos , FN-kappa B/metabolismo , Necrosis , Fase de Descanso del Ciclo Celular/efectos de los fármacos , Células Tumorales Cultivadas
11.
Cancer Lett ; 159(2): 189-95, 2000 Oct 31.
Artículo en Inglés | MEDLINE | ID: mdl-10996731

RESUMEN

The effects of water-soluble chitosan oligomers (WSCO) on the synthesis of nitric oxide (NO) by murine peritoneal macrophages and on macrophage-mediated cytotoxicity towards murine fibrosarcoma Meth A cells were investigated. WSCO alone had no effect on NO synthesis and killing of tumor cells. However, treatment of macrophages with a combination of WSCO and interferon-gamma (IFN-gamma) synergically increased NO synthesis and enhanced killing of tumor cells. The synergism between IFN-gamma and WSCO in NO synthesis and tumoricidal activity was mainly dependent on increased secretion of tumor necrosis factor-alpha by WSCO.


Asunto(s)
Quitina/análogos & derivados , Quitina/farmacología , Citotoxicidad Inmunológica/efectos de los fármacos , Interferón gamma/farmacología , Macrófagos Peritoneales/efectos de los fármacos , Óxido Nítrico/biosíntesis , Animales , Anticuerpos Monoclonales/farmacología , Quitosano , Medios de Cultivo Condicionados/farmacología , Relación Dosis-Respuesta a Droga , Sinergismo Farmacológico , Macrófagos Peritoneales/inmunología , Macrófagos Peritoneales/metabolismo , Ratones , Ratones Endogámicos C57BL , Óxido Nítrico Sintasa/efectos de los fármacos , Óxido Nítrico Sintasa/metabolismo , Óxido Nítrico Sintasa de Tipo II , Solubilidad , Células Tumorales Cultivadas/citología , Células Tumorales Cultivadas/efectos de los fármacos , Factor de Necrosis Tumoral alfa/inmunología , Factor de Necrosis Tumoral alfa/metabolismo
12.
Leuk Res ; 25(4): 339-46, 2001 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-11248331

RESUMEN

Water-soluble chitosan oligomer (WSCO) has been reported to have anticancer activity, immuno-enhancing effect and antimicrobial activity. However, other biological activities are unknown. Herein, we have shown that WSCO is able to inhibit proliferation of human leukemia HL-60 cells and induce these cells to differentiate. Treatment with WSCO for 4 days resulted in a concentration-dependent reduction in HL-60 cell growth as measured by cell counting and MTT assay. This effect was accompanied by a marked increase in the proportion of G(0)/G(1) cells as measured by flow cytometry. WSCO also induced differentiation of the cells as measured by phorbol ester-dependent reduction of NBT, morphological changes as examined by Wright-Giemsa staining and expression of CD11b but not of CD14 as analysed by flow cytometry, indicating differentiation of HL-60 cells toward granulocyte-like cells. A combination of low dose of WSCO with all-trans retinoic acid, a differentiating agent toward granulocyte-like cells, exhibited a synergistic effect on the differentiation. In addition, treatment of HL-60 cells with WSCO for 6 or 8 days resulted in the induction of apoptosis as assayed qualitatively by agarose gel electrophoresis and quantitatively by Annexin V technique using flow cytometry. Collectively, there is a potential for WSCO in the treatment of myeloid leukemia.


Asunto(s)
Diferenciación Celular/efectos de los fármacos , Quitina/farmacología , Granulocitos/citología , Leucemia Promielocítica Aguda/tratamiento farmacológico , Antineoplásicos/farmacología , Apoptosis/efectos de los fármacos , Ciclo Celular/efectos de los fármacos , División Celular/efectos de los fármacos , Quitina/análogos & derivados , Quitosano , Relación Dosis-Respuesta a Droga , Sinergismo Farmacológico , Células HL-60/efectos de los fármacos , Células HL-60/patología , Humanos , Leucemia Promielocítica Aguda/patología , Tretinoina/farmacología
13.
Mol Cells ; 12(2): 178-84, 2001 Oct 31.
Artículo en Inglés | MEDLINE | ID: mdl-11710518

RESUMEN

Experimental autoimmune uveoretinitis (EAU) is a T cell-mediated autoimmune disease of posterior uvea that closely resembles a human disease. The uveitogenic effector T cell has a Th1-like phenotype [high interferon-gamma (IFN-gamma), low interleukin-4 (IL-4)], and genetic susceptibility to EAU that is associated with an elevated Th1 response. Suppression of CD4+ Th1 cells for the treatment of autoimmune disease is an attractive potential therapeutic approach. Nitric oxide (NO) has been implicated in the pathogenesis of several inflammatory and autoimmune diseases. In this study, we investigated the potential role of NO as an immunoregulator to alter Th1/Th2 cytokine production, as well as to inhibit the interphotoreceptor retinoid binding protein (IRBP)-induced EAU, a CD4+ Th1 cell-mediated autoimmune disease. Injection of IRBP (100 microg) into two footpads resulted in severe EAU. The beginning peak of the disease was days 12 to 15 after immunization. Oral treatment with molsidomine (MSDM), a NO donor, began 24 h before IRBP immunization to the end of the experiments, which resulted in a significant inhibition of the disease by clinical and histopathological criteria. When MSDM was administered until day 21, a complete reduction of incidence and severity of EAU was observed. To investigate the cytokine alterations from Th1 to Th2 cytokines by MSDM, the cytokines were assayed in a culture medium of IRBP-stimulated inguinal lymphocytes. IRBP-immunized rats secreted a high concentration of IFN-gamma and a low concentration of IL-10. In contrast, MSDM treatment enhanced IL-10 secretion and tended to decrease IFN-gamma secretion. In conclusion, we show that the administration of NO suppresses EAU by altering the Th1/Th2 balance of inflammatory immune responses. We suggest that NO may be useful in the therapeutic control of autoimmune uveitis.


Asunto(s)
Enfermedades Autoinmunes/inmunología , Enfermedades Autoinmunes/prevención & control , Proteínas del Ojo , Donantes de Óxido Nítrico/farmacología , Óxido Nítrico/inmunología , Retinitis/inmunología , Retinitis/prevención & control , Células TH1/efectos de los fármacos , Células TH1/inmunología , Uveítis/inmunología , Uveítis/prevención & control , Animales , Enfermedades Autoinmunes/patología , Modelos Animales de Enfermedad , Humanos , Inmunización , Interferón gamma/biosíntesis , Interleucina-10/biosíntesis , Masculino , Molsidomina/farmacología , Ratas , Ratas Endogámicas Lew , Retinitis/patología , Proteínas de Unión al Retinol/inmunología , Células Th2/efectos de los fármacos , Células Th2/inmunología , Uveítis/patología
14.
Int Immunopharmacol ; 4(3): 377-86, 2004 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-15037215

RESUMEN

We investigated the effects of the gallotannin penta-O-galloyl-beta-d-glucose (PGG) on interleukin (IL)-8 gene expression and nuclear factor (NF)-kappaB activation. PGG inhibited IL-8 production and gene expression in human monocytic U937 cells stimulated with phorbol myristate acetate (PMA), as measured by enzyme-linked immunosorbent assay and reverse transcription-polymerase chain reaction analysis, respectively. PGG also inhibited PMA-mediated NF-kappaB activation, as measured by electromobility shift assay. Furthermore, PGG prevented PMA-mediated degradation of the NF-kappaB inhibitory protein I-kappaBalpha, as measured by Western blot analysis. PGG also inhibited both IL-8 production and NF-kappaB activation in the U937 cells stimulated with tumor necrosis factor-alpha. These results suggest that PGG, a major constituent of the root cortex of Paeonia suffruticosa ANDREWS, can inhibit IL-8 gene expression by a mechanism involving its inhibition of NF-kappaB activation, which is dependent on I-kappaBalpha degradation.


Asunto(s)
Antiinflamatorios no Esteroideos/farmacología , Taninos Hidrolizables/farmacología , Interleucina-8/antagonistas & inhibidores , FN-kappa B/antagonistas & inhibidores , Acetato de Tetradecanoilforbol/farmacología , Transporte Activo de Núcleo Celular , Western Blotting , Ensayo de Cambio de Movilidad Electroforética , Ensayo de Inmunoadsorción Enzimática , Regulación de la Expresión Génica , Humanos , Proteínas I-kappa B/metabolismo , Interleucina-8/biosíntesis , Interleucina-8/genética , Transporte de Proteínas , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Factores de Tiempo , Células U937
15.
Int Immunopharmacol ; 1(4): 777-84, 2001 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-11357890

RESUMEN

High amounts of nitric oxide (NO) production following the induction of inducible NO synthase (iNOS) gene expression has been implicated in the pathogenesis of inflammatory diseases. Capsaicin, a vanilloid receptor agonist, is known to have an inhibitory effect on NO production in macrophages. In the present study, we have found that capsazepine (CAPZ), a vanilloid receptor antagonist, also inhibited NO and iNOS protein syntheses induced by lipopolysaccharide in RAW264.7 macrophages via the suppression of iNOS mRNA. The mechanistic studies showed that CAPZ inhibited the expression of iNOS mRNA through the inactivation of nuclear transcription factor-kappa B (NF-kappa B). Thus, capsazepine may be a useful candidate for the development of a drug to treat inflammatory diseases related to iNOS gene overexpression.


Asunto(s)
Capsaicina/análogos & derivados , Capsaicina/farmacología , Lipopolisacáridos/farmacología , Macrófagos/enzimología , FN-kappa B/antagonistas & inhibidores , Óxido Nítrico Sintasa/antagonistas & inhibidores , Receptores de Droga/antagonistas & inhibidores , Animales , Línea Celular , Regulación Enzimológica de la Expresión Génica/efectos de los fármacos , Ratones , Óxido Nítrico/biosíntesis , Óxido Nítrico Sintasa/genética , Óxido Nítrico Sintasa de Tipo II , ARN Mensajero/análisis
16.
Int Immunopharmacol ; 2(8): 1173-81, 2002 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-12349954

RESUMEN

Catalposide, the major iridoid glycoside isolated from the stem bark of Catalpa ovata G. Don (Bignoniaceae), was found to inhibit the productions of tumor necrosis factor-alpha (TNF-alpha), interleukin-1beta (IL-1beta), and interleukin-6 (IL-6), and the activation of nuclear factor kappaB (NF-kappaB) in RAW 264.7 macrophages activated with lipopolysaccharide (LPS). Catalposide also inhibited the expressions of TNF-alpha, IL-1beta, and IL-6 genes and the nuclear translocation of p65 subunit of NF-kappaB in LPS-activated RAW 264.7 cells. Flow cytometric analysis revealed that catalposide suppressed the binding of FITC-conjugated LPS to CD14 on the surface of cells, probably resulting in the inhibitory effects on TNF-alpha, IL-1beta, and IL-6 productions and NF-kappaB activation. These findings suggest that catalposide could be an attractive candidate for adjunctive therapy in gram-negative bacterial infections.


Asunto(s)
Bignoniaceae , Glucósidos/farmacología , Interleucina-1/antagonistas & inhibidores , Interleucina-6/antagonistas & inhibidores , Macrófagos/efectos de los fármacos , FN-kappa B/antagonistas & inhibidores , Animales , Bignoniaceae/química , Línea Celular , Glucósidos/química , Glucósidos/aislamiento & purificación , Glicósidos/química , Glicósidos/aislamiento & purificación , Glicósidos/farmacología , Interleucina-1/biosíntesis , Interleucina-6/biosíntesis , Lipopolisacáridos/farmacología , Macrófagos/metabolismo , Ratones , FN-kappa B/metabolismo , Corteza de la Planta , Extractos Vegetales/química , Extractos Vegetales/aislamiento & purificación , Extractos Vegetales/farmacología
17.
Toxicol In Vitro ; 17(1): 49-57, 2003 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-12537962

RESUMEN

Recently we have reported that the trichothecene mycotoxin 4-acetyl-12,13-epoxyl-9-trichothecene-3,15-diol (AETD) from the fruiting bodies of Isaria japonica Yasuda is a potent inducer of apoptosis in human promyelocytic HL-60 cells. The present study aims to characterize the molecular events leading to AETD-induced apoptosis in HL-60 cells. The percentage of apoptotic cells (annexin-V-positive cell population) increased dose- and time-dependently after AETD exposure. Apoptosis of HL-60 cells by AETD was associated with the formation of intracellular reactive oxygen species (ROS), the depletion of intracellular glutathione (GSH) and the activation of caspase-3. Pretreating the cells with the antioxidant N-acetyl-L-cystein (NAC) and the caspase-3 inhibitor Z-DEVD-fmk abrogated AETD-induced apoptosis and caspase-3 activation. NAC blocked intracellular ROS formation and GSH depletion, but Z-DEVD-fmk did not. These results indicate that AETD induces apoptosis in HL-60 cells by causing intracellular ROS formation and GSH depletion followed by the downstream event of caspase-3 activation.


Asunto(s)
Apoptosis/efectos de los fármacos , Ascomicetos/química , Especies Reactivas de Oxígeno/efectos adversos , Tricotecenos/farmacología , Caspasa 3 , Caspasas/farmacología , Relación Dosis-Respuesta a Droga , Glutatión/metabolismo , Células HL-60 , Humanos
18.
J Ethnopharmacol ; 70(2): 177-82, 2000 May.
Artículo en Inglés | MEDLINE | ID: mdl-10771208

RESUMEN

The whole plant of Sedum sarmentosum (SS) has been traditionally used for the treatment of chronic viral hepatitis in China and South Korea. Certain hepatitis virus causes acute and chronic hepatitis and induces hepatocellular carcinoma (HC). In the present study, we examined whether the crude alkaloid fraction (CAF) of SS had any anticancer effects on hepatoma cell lines. Murine hepatoma (BNL CL. 2) and human hepatoma (HepG2) cell lines were cultured in the presence of CAF of SS at various doses (50-150 microg/ml) for 24 or 48 h. CAF caused a dose-dependent inhibition of cell proliferation without necrosis or apoptosis. Antiproliferative effects of CAF of SS were associated with an increase in the number of cells in the G1 phase of cell cycle. This study suggests that SS may improve survival of hepatoma patients via the inhibition of excessive growth of tumor cells.


Asunto(s)
Alcaloides/farmacología , Antineoplásicos Fitogénicos/farmacología , Carcinoma Hepatocelular/tratamiento farmacológico , Neoplasias Hepáticas/tratamiento farmacológico , Plantas Medicinales , Animales , Ciclo Celular/efectos de los fármacos , División Celular/efectos de los fármacos , Humanos , Corea (Geográfico) , Ratones , Células Tumorales Cultivadas
19.
J Ethnopharmacol ; 68(1-3): 209-17, 1999 Dec 15.
Artículo en Inglés | MEDLINE | ID: mdl-10624880

RESUMEN

It is well established that nitric oxide (NO) and superoxide radicals play pivotal roles in the pathogenesis of inflammatory diseases and fever. This study is undertaken to address whether the methanol extract of Spiraea prunifolia var. simpliciflora root, a traditional medicine as an antipyretic, modulates the generation of NO and superoxide in IFN-gamma primed or polymyristic acetate (PMA) stimulated RAW 264.7 cells, respectively. The generation of NO as well as the expression of inducible nitric oxide synthase (iNOS) protein from IFN-gamma primed RAW 264.7 cells is markedly decreased by the methanol extract in a dose dependent manner. However, the methanol extract does not affect the viability of RAW 264.7 cells, as assessed by methylthiazol-2-yl-2,5-diphenyl tetrazolium bromide (MTT) assay. In addition, the methanol extract suppresses the generation of superoxide in PMA-stimulated RAW 264.7 cells in a dose and a time dependent manner. Taken together, anti-pyretic effects of Spiraea prunifolia var. simpliciflora root extract could result from direct suppression of NO and decreased superoxide generation.


Asunto(s)
Supervivencia Celular/efectos de los fármacos , Macrófagos/efectos de los fármacos , Macrófagos/metabolismo , Óxido Nítrico/biosíntesis , Extractos Vegetales/farmacología , Raíces de Plantas/química , Superóxidos/metabolismo , Analgésicos no Narcóticos/farmacología , Animales , Western Blotting , Células Cultivadas , Relación Dosis-Respuesta a Droga , Interferón gamma/farmacología , Medicina Tradicional , Metanol/química , Ratones , Ácido Mirístico/farmacología , Óxido Nítrico Sintasa/efectos de los fármacos , Óxido Nítrico Sintasa/metabolismo , Óxido Nítrico Sintasa de Tipo II , Solubilidad , Factores de Tiempo
20.
J Ethnopharmacol ; 73(1-2): 323-7, 2000 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-11025173

RESUMEN

The aim of this study was to investigate the effect of butanol fraction of the aqueous extract of Forsythia koreana fruits on the nitric oxide (NO) production and inducible nitric oxide synthesis (iNOS) gene expression in murine macrophage-like RAW 264.7 cells. Butanol fraction alone affected neither NO production nor iNOS gene expression in macrophage-like RAW 264.7 cells. However, the butanol fraction inhibited NO production and iNOS gene expression in RAW 264. 7 cells stimulated with interferon-gamma (IFN-gamma) and lipopolysaccharide (LPS). These findings suggest that inhibition of NO production by this butanol fraction in RAW 264.7 cells stimulated with IFN-gamma plus LPS was due to the suppression of iNOS gene expression.


Asunto(s)
Butanoles/farmacología , Macrófagos/efectos de los fármacos , Óxido Nítrico/biosíntesis , Extractos Vegetales/farmacología , Análisis de Varianza , Animales , Butanoles/aislamiento & purificación , Células Cultivadas , Interferón gamma/farmacología , Macrófagos/metabolismo , Ratones , Plantas Medicinales
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA